Abstract
Collagen-I (Col) and hyaluronic acid (HA) are two of the most important extracellular matrix (ECM) components. While collagen serves as the main structural feature of the ECM and is an important ligand for integrin-based adhesions, HA acts as a ligand for the transmembrane glycoprotein CD44. However, most studies on cancer invasion utilize 3D collagen matrices, thereby ignoring the importance of HA–CD44 interactions. Here, we describe the process of fabricating Col–HA gels with varying Col/HA ratios, which can be used to suitably mimic the tumor microenvironment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ropponen K, Tammi M, Parkkinen J et al (1998) Tumor cell-associated hyaluronan as an unfavourable prognostic factor in colorectal cancer. Cancer Res 58:342–347
Setälä LP, Tammi MI, Tammi RH et al (1999) Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate. Br J Cancer 79:1133–1138
Cheng XB, Sato N, Kohi S et al (2013) Prognostic impact of hyaluronan and its regulators in pancreatic ductal adenocarcinoma. PLoS One 8:e80765
Levental KR, Yu H, Kass L et al (2010) Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139:891–906
Peach RJ, Hollenbaugh D, Stamenkovic I et al (1993) Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J Cell Biol 122:257–264
Laurich C, Wheeler MA, Iida J et al (2004) Hyaluronan mediates adhesion of metastatic colon carcinoma cells. J Surg Res 122:70–74
Herrera-Gayol A, Jothy S (2001) Effects of hyaluronan on the invasive properties of human breast cancer cells in vitro. Int J Exp Pathol 82:193–200
Simpson MA, Wilson CM, Furcht LT et al (2002) Manipulation of hyaluronan synthase expression in prostate adenocarcinoma cells alters pericellular matrix retention and adhesion to bone marrow endothelial cells. J Biol Chem 277:10050–10057
Lokeshwar V, Schroeder G, Hautmann S et al (2001) Hyaluronic acid and hyaluronidase: accurate tumor markers and tumor progression regulators. ScientificWorldJournal 1:106
Orian-Rousseau V, Chen L, Sleeman JP et al (2002) CD44 is required for two consecutive steps in HGF/c-Met signaling. Genes Dev 16:3074–3086
Zöller M (2011) CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev Cancer 11:254–267
Sugahara KN, Murai T, Nishinakamura H et al (2003) Hyaluronan oligosaccharides induce CD44 cleavage and promote cell migration in CD44-expressing tumor cells. J Biol Chem 278:32259–32265
Alaniz L, García M, Cabrera P et al (2004) Modulation of matrix metalloproteinase-9 activity by hyaluronan is dependent on NF-kappaB activity in lymphoma cell lines with dissimilar invasive behavior. Biochem Biophys Res Commun 324:736–743
Das A, Monteiro M, Barai A et al (2017) MMP proteolytic activity regulates cancer invasiveness by modulating integrins. Sci Rep 7:14219
Kumar S, Das A, Barai A et al (2018) MMP secretion rate and inter-invadopodia spacing collectively govern cancer invasiveness. Biophys J 114:650–662
Patwardhan S, Mahadik P, Shetty O et al (2021) ECM stiffness-tuned exosomes drive breast cancer motility through thrombospondin-1. Biomaterials 279:121185
Gorelik R, Gautreau A (2014) Quantitative and unbiased analysis of directional persistence in cell migration. Nat Protoc 9:1931–1943
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Dutta, S., Sen, S. (2024). Preparation and Characterization of Collagen–Hyaluronic Acid (Col–HA) Matrices: In Vitro Mimics of the Tumor Microenvironment. In: Santamaria, S. (eds) Proteases and Cancer. Methods in Molecular Biology, vol 2747. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3589-6_11
Download citation
DOI: https://doi.org/10.1007/978-1-0716-3589-6_11
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-3588-9
Online ISBN: 978-1-0716-3589-6
eBook Packages: Springer Protocols